Table 2. The 3-year and 5-year OS rate of each subgroup of LNR.
| Subgroup No. | LNR | No. of patients | 3-year OS (%) | 5-year OS (%) | P-value* |
|---|---|---|---|---|---|
| 1 | 0 | 84 | 86.9 | 84.2 | |
| 2 | 0.01–0.10 | 69 | 78.3 | 62.1 | 0.003 |
| 3 | 0.11–0.20 | 47 | 44.7 | 31.1 | <0.001 |
| 4 | 0.21–0.30 | 23 | 52.2 | 33.2 | 0.832 |
| 5 | 0.31–0.40 | 19 | 26.3 | 6.6 | 0.107 |
| 6 | 0.41–0.50 | 11 | 27.3 | 13.6 | 0.684 |
| 7 | 0.51–0.60 | 5 | 6 | 2 | 0.122 |
| 8 | 0.61–0.70 | 3 | 0 | 0 | 0.004 |
| 9 | 0.71–0.80 | 1 | 0 | 0 | 0.182 |
| 10 | 0.81–0.90 | 3 | 0 | 0 | 0.515 |
LNR = lymph node ratio; OS = overall survival.
*P-value of each neighborhood subgroup using the log-rank test.